Publikace
- 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease2021 | Publikace bez příslušnosti k fakultě
- Discovery of multifunctional anti-Alzheimer's agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and gamma-aminobutyric acid transporters2021 | Publikace bez příslušnosti k fakultě
- Profiling donepezil template into multipotent hybrids with antioxidant properties2018 | Publikace bez příslušnosti k fakultě
- Alzheimer's disease drugs - In Vitro comparison of cholinesterase inhibition and beta-amyloid modulation2017 | Farmaceutická fakulta v Hradci Králové
- Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer's disease2017 | Publikace bez příslušnosti k fakultě
- 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment2015 | Publikace bez příslušnosti k fakultě
- 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE12023 | Farmaceutická fakulta v Hradci Králové
- Recent advances in dopamine D-2 receptor ligands in the treatment of neuropsychiatric disorders2023 | Publikace bez příslušnosti k fakultě
- Novel D-2/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatment2022 | Ústřední knihovna
- UHPLC-HRMS study of pharmacokinetics of a novel hybrid cholinesterase inhibitor K1234: A comparison between in silico, in vitro and in vivo data2022 | Lékařská fakulta v Hradci Králové
Loading network view...